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medication or duration of treatment, poor objective sleep 
patterns at diagnosis predicted both poor psychological 
functioning and poor sleep about 3 years after diagnosis. 
The pattern of results suggests the need for more thorough 
medical and psychotherapeutic treatment and monitoring 
of patients with RLS.  Copyright © 2010 S. Karger AG, Basel 
 Introduction 
 Restoring sleep is strongly associated with daily well-
being and functioning  [1] , memory  [2, 3] , emotional intel-
ligence  [4] , learning capacity, and academic performance 
 [5] . By contrast, chronic sleep disturbances adversely af-
fect physical and psychological functioning in both ado-
lescents  [6] and adults  [7, 8] . Furthermore, sleep com-
plaints and insomnia in adults seem to be on the increase 
worldwide  [9, 10] .
 Amongst the variety of possible factors adversely af-
fecting sleep, restless legs syndrome (RLS) has been de-
scribed as ‘the most common disorder you ever heard of ’ 
 [11] . RLS is a distressing sensorimotor disorder. An al-
teration of iron-dopamine connections  [12, 13] as well as 
genetic factors  [14] have been implicated in its etiology.
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 Abstract 
 Background: Amongst the variety of disorders affecting 
sleep, restless legs syndrome (RLS) merits particular atten-
tion. Little is known about long-term outcomes for sleep
or psychological functioning following a diagnosis of RLS. 
The aim of the present study was thus to evaluate sleep and 
psychological functioning at a 3-year follow-up and based 
on polysomnographic measurements.  Method: Thirty-eight 
patients (18 female and 20 male patients; mean age: 56.06, 
SD = 12.07) with RLS and sleep electroencephalographic re-
cordings were followed-up 33 months later. Participants 
completed a series of self-rating questionnaires related to 
sleep and psychological functioning. Additionally, they com-
pleted a sleep log for 7 consecutive days.  Results: Age, male 
gender, increased light sleep (S1, S2) and sleep onset latency, 
along with low sleep efficiency, predicted psychological 
functioning and sleep 33 months later. Specifically, sleep 
fragmentation predicted poor psychological functioning, 
and both sleep fragmentation and light sleep predicted 
poor sleep.  Conclusions: In patients with RLS, irrespective of 
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 For several reasons, RLS demands particular atten-
tion. First, prevalence rates range from 5 to 10% in the 
United States and other Western countries  [15, 16] . Sec-
ond, RLS does not only affect adults: it is also observed in 
children and adolescents  [17–19] . Third, RLS is associated 
with a broad variety of additional psychiatric disorders. 
Several studies have reported the co-occurrence of RLS 
and depressive symptoms  [11, 18, 20–26] . In particular, 
patients suffering from RLS have shown poor polysom-
nographic sleep patterns, compared both to healthy con-
trols  [27] and patients suffering from major depressive 
disorders  [25, 26] . In this respect, Hornyak et al.  [26] ob-
served that several antidepressants may trigger or aggra-
vate RLS. By contrast, mild to moderate depressive symp-
toms often seem to be relieved, with improvements in 
RLS symptoms, after administration of dopamine recep-
tor agonists. Furthermore, 83.3% of the patients with dys-
thymia, 63.6% of those with general anxiety disorders, 
and 60% of those with panic disorder reported the occur-
rence of RLS before the onset of the psychiatric disorder 
 [24] . Recent findings from a population-based survey in 
South Korea suggest that the prevalence of RLS there may 
be substantially lower than in Western countries, though 
the occurrence of RLS was strongly associated with major 
depressive disorders, panic disorders, and posttraumatic 
stress disorder  [28] .
 The occurrence of RLS is associated with poor quality 
of life and with particular personality traits. Happe et al. 
 [29] , for example, assessed 519 patients suffering from 
RLS in a cross-sectional study and observed that health-
related quality of life was substantially affected, com-
pared to indices for the general population. Severity of 
RLS and depressive symptoms had the most significant 
influence on deteriorated health-related quality of life. 
Likewise, a series of cross-sectional studies have identi-
fied poorer quality of life and psychological functioning 
among patients suffering from RLS as compared to con-
trols [for a comprehensive overview, see ref.  29 ]. In a sim-
ilar vein, based on the 5-factor model of personality pro-
posed by Costa and McCrae  [30] , Kalaydjian et al.  [31] 
investigated differences in personality traits between 
 patients suffering from RLS and controls. The results 
showed significant differences on neuroticism, but not on 
openness, agreeableness, conscientiousness, or extraver-
sion, i.e., compared to controls, patients suffering from 
RLS had higher scores for anxiety, anger/hostility, and 
depression.
 Long-term treatment outcomes of RLS have focused 
exclusively on the impact of medication  [32–38] , though 
with conflicting results: whereas some studies have re-
ported a marked decrease in RLS  [37] and exceptional 
efficacy for RLS-related medication  [32] , others have re-
ported either increased severity of symptoms  [35] or only 
symptomatic relief rather than any curative effect  [32] . 
However, nothing is known about the extent to which 
polysomnographic sleep patterns may predict long-term 
development of sleep or psychological functioning in pa-
tients with diagnosed RLS. The aim of the present study 
was thus to relate sleep electroencephalographic (EEG) 
values to self-reported sleep and psychological function-
ing about 3 years later.
 Since specific long-term data have not been available 
until now, no hypotheses were formulated. As a conse-
quence, an exploratory approach was adopted.
 Methods 
 Sample and Procedure 
 A sample of 63 patients (30 females and 33 males) was diag-
nosed in our Sleep Research Unit between April 2001 and October 
2005 (mean age 51.76 years, SD = 15.34)  [25] . At first contact, a 
thorough assessment was made, including a brief psychiatric in-
terview, diagnosis of RLS, and polysomnographic EEG record-
ings. These patients were subsequently recontacted, the follow-up 
occurring on average 33 months later (SD = 13.28; range 18–63 
months). The response rate was 61% (38 participants 1 : 18 female 
(47.5%) and 20 male (52.5%) patients; mean age 55.32 years, SD = 
12.33) 2 .
 Patients were contacted by telephone and asked to participate 
in a follow-up study consisting of a set of questionnaires (see be-
low) concerning current sleep, quality of life, medication intake 
and psychological functioning. The purposes of the study were 
fully explained. Participants received the questionnaires and the 
informed consent by mail. All participants received a reward of 
CHF 40.00 for participation. The experimental protocol was ap-
proved by the local ethics committee.
 Materials 
 Initial Assessment of Sleep by Polysomnography 
 All patients slept in the Sleep Research Unit for one night. 
Sleep was recorded between 11 p.m. (lights off) and 7 a.m. (lights 
on) using standard polysomnography procedures, namely a hori-
zontal electrooculogram, a submental myogram and an EEG re-
cording: C3–A2, C4–A1, C3–C4) as well as an electrocardiogram. 
The sleep records were visually scored by two experienced raters 
 1   Of the 25 nonparticipants, 2 had died, 6 were hospitalized, 7 could not 
be contacted, and 10 refused to participate due to lack of interest or time. 
 2   Participants at follow-up did not differ from nonparticipants with re-
spect to gender distribution (participants: male:female = 18:20; nonpar-
ticipants: male:female = 12:13;   2 (1) = 0.002, p = 0.961), age (participants: 
55.32 years (SD = 12.33); nonparticipants: 57.67 years (SD = 10.21) = t(61) = 
0.65, p = 0.52), or initial sleep EEG profiles (all ts  ! 1). Thus, there was no 
systematic bias between participants and nonparticipants. 
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according to standardized criteria  [39] . Twenty percent of the 
sleep records were independently rescored. Inter-rater reliability 
was r = 0.92. The sleep parameters were analyzed according to the 
definitions in the standard program described by Lauer et al. [ 40 ; 
also see ref. 25 ] 3 .
 Assessments at Follow-Up 
 Depressive Symptoms 
 Participants completed the Beck Depression Inventory  [41] 
providing self-rating of depressive disorders. The higher the over-
all score, the more the respondent is taken to suffer from depres-
sive symptoms (Cronbach’s   = 0.89).
 Restless Legs Syndrome 
 Following the International RLS Study group  [42] , a diagnosis 
of RLS is given if patients answer ‘yes’ to the following 6 questions: 
(1) symptoms of leg restlessness; (2) unpleasant creepy/crawly 
feelings in the legs; (3) co-occurrence of leg restlessness and un-
pleasant feelings in the legs; (4) occurrence of these feelings main-
ly at rest, (5) improvement with movement, and (6) worsening of 
these sensations in the evening or at night as compared to the 
morning [ 43 ; Cronbach’s   = 0.88].
 Sleep Disturbances 
 Five items were taken from the Insomnia Severity Index [ 44 ; 
Cronbach’s   = 0.90]. (1) To assess insomnia, participants were 
asked the following questions: ‘In the last two weeks, how much 
did you suffer from the following disturbances: difficulty falling 
asleep, difficulties maintaining sleep, early morning awakening, 
increased daytime sleepiness?’ Answers were given on a 5-point 
rating scale ranging from 0 = ‘not at all’ to 4 = ‘very much’.
(2) ‘How satisfied are you with your sleep?’ Answers were given 
on a 5-point scale ranging from 0 = ‘very satisfied’ to 4 = ‘very 
dissatisfied’. (3) ‘How much does sleep disturbance have a nega-
tive impact on your daily performance?’ Answers were given on a 
5-point scale ranging from 0 = ‘not at all’ to 4 = ‘very much’. (4) 
‘How much do you think that other people are aware that your 
sleep disturbance negatively influences your daily performance?’ 
Answers were given on a 5-point scale ranging from 0 = ‘not at all’ 
to 4 = ‘very much’. (5) ‘How much are you actually worried about 
your sleep disturbance?’ Answers were given on a 5-point scale 
ranging from 0 = ‘not at all’ to 4 = ‘very much’. The higher the 
mean score, the more the person is assumed to suffer from insom-
nia. This mean score was labeled ‘Insomnia Severity’.
 Sleep-Related Personality Traits 
 Participants also completed a single sleep-related personality 
questionnaire, i.e. a questionnaire specifically designed to assess 
personality traits of patients with sleep complaints ( F ragebogen 
zur  E rfassung allgemeiner  P ersönlichkeitsmerkmale  S chlaf-
gestörter; Questionnaire for Assessing General Personality Traits 
of Patients Suffering from Sleep Disorders; FEPS-I and II) [ 45 ; 
Cronbach’s   for internal consistency for both FEPS I and II = 
0.89]. The FEPS-I questionnaire consists of 64 items describing 6 
sleep-related personality traits and subjective sleep quality. An-
swers are given on a 5-point scale ranging from ‘is not true at all’ 
to ‘is completely true’. The dimensions are presented in  table 1 . 
The underlying rationale for these two dimensions is that dys-
functional, or negative cognitions such as continually worrying 
about not being able to sleep or about unresolved problems are the 
main factors in the development and persistence of sleep prob-
lems  [45–47] . The sleep-related personality questionnaire was 
chosen because it has been shown to be suitable both for patients 
suffering from sleep disorders and for healthy subjects  [45, 48, 49] .
 3   With respect to the medication during polysomnographic assessment, 
as in the former study  [25] , no systematic bias between sleep-altering and 
non-sleep-altering medications on sleep EEG profiles was observed. 
Table 1. D imensions of FEPS I and II
Dimensions P oles
positive pole negative pole
FEPS I
Attitude towards life Satisfied, confident, positive Depressive, dissatisfied, resigned, lacking emotion
Self-confidence Self-confident, resolute, carefree Anxious, unsure, indecisive, easily irritated
Mental arousal Relaxed, balanced, calm Tense, irritable, exhausted, burdened
Physical arousal Relaxed, balanced, without any complaints Nervous, over-agitated, complaining
Aggressive behavior1 Externalizing, competitive, asserting own opinion Internalizing, over-controlling, inhibited, evasive
Self-perception of body sensations Easy-going, carefree, confiding Hypochondriac, complaining
Subjective sleep quality2 Regenerative, undisturbed, unimpaired Impaired, disturbed, not regenerative
FEPS II
Focusing Easy-going, carefree, confiding with regard to sleep Concerned about sleep; preoccupied about not falling 
asleep, not sleeping enough to feel restored
Rumination Optimistic about coping with problems Concerned and preoccupied about unresolved problems
FE PS = Fragebogen zur Erfassung allgemeiner Persönlichkeitsmerkmale Schlafgestörter [45].
1 The expression ‘aggressive behavior’ proposed by the test authors, may be misleading; the dimension should perhaps be translated as ‘assertive be-
havior’. 2 To avoid artificial associations between this dimensions and target variables related to sleep, the dimension Subjective sleep quality was not 
included in the statistical computations.
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 Daily Sleep Log 
 The sleep log was based on the Pittsburgh Sleep Quality Index 
 [50]  the German adaptation of which was taken from a conven-
tional and widely used manual for psychological treatment of 
sleep complaints  [51] . In contrast to this index, the adapted sleep 
log was completed consecutively. Participants were asked to fill it 
out twice a day for a week – in the evening and in the morning. In 
the evening, participants responded to questions about daytime 
sleepiness (1 = ‘high daytime sleepiness’), physical activity (1 = 
‘low physical activity’), concentration (1 = ‘low concentration’), 
and mood (1 = ‘very bad mood’) on 8-point scales. In the morn-
ing, the questionnaire asked about sleep quality (1 = ‘very bad 
sleep quality’), mood (1 = ‘very bad mood’), using the same scales. 
In addition, sleep onset latency (SOL, in minutes), awakenings 
after sleep onset (number), and total sleep time (in hours) was re-
quested (Cronbach’s   = 0.89). Nights were defined as weekday 
nights if the participant went to work the following day; accord-
ingly, weekend nights were Friday and Saturday nights. Two sep-
arate composite variables were calculated for weekdays and week-
end days, respectively.
 Assessment of Current Medication 
 Participants were asked to record any current medications. In 
particular, they were asked whether they were currently taking 
any medications relating to RLS or depressive symptoms. Medica-
tions were labeled as follows: medication 1 (antidepressants, such 
as mirtazapine, duloxetine, trimipramine, ‘yes’ vs. ‘no’), medica-
tion 2 (RLS-related medications, such as pramipexole, gabapen-
tine, ropinirole, ‘yes’ vs. ‘no’), and medication 3 (benzodiazepines, 
such as midazolame, diazepame, clonazepame, ‘yes’ vs. ‘no’).
 Assessing Quality of Life 
 The Skala zur Erfassung der Lebensqualität (Scale for the As-
sessment of Quality of Life, SEL)  [52] was administered to assess 
quality of life. The questionnaire consists of 67 items and assesses 
current mood (e.g. ‘At the moment, I feel abysmal’), objective and 
subjective physical state (e.g., for objective, ‘I have difficulties or I 
have observed changes in the heart and lungs, such as shortness 
of breath, heart irregularity; for subjective, ‘Over recent weeks, I 
have had a lot of pain’), objective and subjective social environ-
ment (e.g., for objective, ‘I wish I had more people to share my 
sorrows with’; for subjective, ‘Over the last weeks, it has been com-
forting to talk to my family’), global mood (e.g. ‘Over the last 
weeks, I have been quite happy’) and orientation to life (e.g. ‘I 
think that also in the future I’ll have many interesting things to 
do’). Answers are given on a 5-point rating scale ranging from 1 
(= not at all true) to 5 (= definitely true; scoring was reversed for 
some items). For the dimensions Mood, Subjective social environ-
ment, Global attitude, and Orientation to life, higher mean scores 
reflect a favorable position on the dimension. For the dimensions 
Objective physical state, Subjective physical state, and Objective 
social environment, higher mean scores reflect an unfavorable 
position on the dimension.
 Statistical Analyses and Preliminary Computations 
 First, to compress and reduce the psychological functioning 
outcome variables [Beck Depression Inventory (BDI), SEL, FEPS 
I and II], a factor analysis was performed with orthogonal rotation 
 [53] . A factor analysis of 16 items from the BDI (total sum score), 
the questionnaires related to quality of life (SEL) and to sleep-re-
lated personality traits (FEPS I and II) yielded 15 factors. The first 
3 had eigenvalues greater than 1, together accounting for 78.4% of 
the overall variance. The first factor, with an eigenvalue of 8.48, 
labeled ‘Psychological arousal and depressive symptoms’, ex-
plained 56.53% of the total variance. The second factor, labeled 
‘External locus of control and rumination’ (eigenvalue 1.97), ex-
plained 13.14% of the total variance. The third factor, labeled ‘So-
cial withdrawal and low social support’ (eigenvalue 1.29) ex-
plained 8.66% of the overall variance. The term ‘Psychological 
functioning’ embraces the dimensions ‘Psychological arousal and 
depressive symptoms’, ‘External locus of control and rumination’, 
and ‘Social withdrawal and low social support’.
 Next, to compress and reduce the results extracted from the 
sleep log, a factor analysis with orthogonal rotation was again 
performed. The factor analysis of 9 variables yielded 8 factors; the 
first 3 had eigenvalues higher than 1, together accounting for 
84.50% of total variance. The first factor, labeled ‘Sleep quality 
and sleep-related mood and behavior’ (eigenvalue 5.56) explained 
59.28% of the total variance. The second factor, labeled ‘Sleep du-
ration and sleep fragmentation’ (eigenvalue 2.13) explained 
17.24% of the total variance. The third factor, labeled ‘Sleep onset 
latency’ (eigenvalue 1.09) explained 7.98% of the overall variance.
 Next, the influence of possible confounding variables was ex-
amined. To this end, a series of multiple-regression analyses (ex-
cluding stepwise backwards) were performed with the 6 new fac-
tors identified above as dependent variables whereas the possible 
confounding variables were identified as independent variables. 
Possible confounding variables considered were age, gender, dif-
ference in years between first assessment and follow-up (termed 
‘RLS duration’), medication 1 (antidepressants ‘yes’ vs. ‘no’), med-
ication 2 (RLS-related medicaments ‘yes’ vs. ‘no’), and medication 
3 (benzodiazepines ‘yes’ vs. ‘no’). It turned out that for all 6 mul-
tiple regression analyses, age, gender, and ‘RLS duration’ were of 
predictive value whereas this was not the case for the variables 
related to medications. Thus, medications were not introduced as 
covariates.
 Next, we examined whether current medication was in any 
way related to former sleep EEG profiles and whether medications 
should thus have been introduced as a factor confounding the re-
lation of sleep EEG variables and current sleep patterns and psy-
chological functioning. To this end, an ANOVA with the factors 
medication 1, medication 2, and medication 3 and the sleep EEG 
profiles as dependent variables was performed. Current medica-
tion was found to be unrelated to former sleep EEG profiles (all Fs 
 ! 1.2). Thus, current medication was not introduced as a possible 
confounding factor between former sleep EEG profiles and cur-
rent sleep patterns and psychological functioning.
 Last, to predict psychological functioning at follow-up (‘Psy-
chological arousal and depressive symptoms’; ‘External locus of 
control and rumination’; ‘Social withdrawal and low social sup-
port’), sleep at follow-up (‘Sleep quality and sleep-related mood 
and behavior’, ‘Sleep duration and sleep fragmentation’; ‘Sleep on-
set latency’; ‘Insomnia Severity’), and occurrence of RLS at follow-
up, a series multiple-regression analyses were performed with age, 
gender, RLS duration and the sleep variables derived from poly-
somnographic sleep recordings as predictors.
 Pearson correlations were computed and analyses were con-
ducted using SPSS 17.0 for Windows.
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 Results 
 Predicting Psychological Functioning 
 Table 2 summarizes the multiple-regression analyses 
with Psychological functioning as outcome variable and 
age, gender, RSL duration, and polysomnographic EEG 
variables as predictors.
 Increased psychological arousal and depressive symp-
toms were predicted by greater age, more awakenings af-
ter sleep onset (amount and duration), a prolonged SOL, 
and increased light sleep (S1 and S2). Greater external lo-
cus of control and rumination were predicted by lower 
age, decreased sleep period time and sleep efficiency, 
more awakenings after sleep onset (number and dura-
tion), and shortened SWS (S3 and S4).
 More marked social withdrawal and lower social sup-
port were predicted by greater age, shortened SPT, a pro-
longed SOL, increased S1 and decreased S4.
 Taken together, along with age, both an increased 
sleep fragmentation and increased light sleep predicted 
poor psychological functioning about three years later.
 Prediction of Sleep 
 Table 3 gives an overview of the multiple regression 
analyses with Sleep (as extracted from the daily sleep log) 
as outcome variable and age, RLS duration, gender, and 
polysomnographic EEG variables as predictors.
 Poorer sleep quality and sleep-related mood and be-
havior were predicted by prolonged RLS duration, male 
gender, lower age, an increased sleep fragmentation, 
along with increased light sleep (S1, S2), decreased S4, and 
increased rapid eye movement (REM)-sleep. Shortened 
Sleep duration and increased sleep fragmentation were 
predicted by increased RLS duration, male gender, more 
awakening after SO (sleep onset; number and duration), 
increased light sleep (S1, S2), decreased S4, and increased 
Table 2.  Multiple linear regression models to describe the influence of age, gender, duration to follow-up, and objective sleep on psy-
chological functioning
Dimension Variables Coefficient Standard
error
Coefficient

95% CI t p R R2 Durbin-
Watson-
statistics
Psychological arousal Intercept –1.58 0.72 – –3.16 to –0.01 –2.21 0.049 0.92 0.85 1.79
and depressive Age 0.049 0.014 0.625 0.02–0.08 3.52 0.005
symptoms WASO 0.126 0.034 2.13 0.05–0.20 3.68 0.004
WASO, time 0.0039 0.008 2.63 0.057 to 0.021 4.82 0.001
SOL 0.062 0.005 1.72 0.04–0.62 5.00 0.000
S1 0.028 0.006 0.455 0.016–0.641 5.06 0.000
S2 0.016 0.007 0.455 0.001–0.030 2.29 0.043
Excluded variables: SWS, S3, SE, gender, S4, SPT, REM-S, RLS duration
External locus of Intercept 22.88 6.74 – 11.86–41.90 3.99 0.003 0.87 0.76 1.61
control and Age 0.074 0.027 0.823 0.015–0.133 2.78 0.020
rumination SPT –0.017 0.006 –1.315 –0.030 to –0.004 2.85 0.017
SE –0.16 0.045 –2.63 –0.264 to –0.064 3.67 0.004
WASO 0.265 0.075 4.24 –0.432 to –0.099 3.55 0.005
WASO, time 0.044 0.014 2.57 0.013–0.074 3.21 0.009
S3 –0.049 0.016 –1.25 –0.084 to –0.014 3.14 0.01
S4 –0.088 0.20 –1.076 0.043 to –0.132 4.35 0.01
Excluded variables: SWS, gender, S1, S2, REM-S, SOL, RLS duration
Social withdrawal Intercept 9.039 2.78 – 2.987–15.09 3.25 0.007 0.83 0.68 2.395
and low Age 0.041 0.018 0.416 0.002–0.080 2.31 0.040
social support SPT –0.018 0.006 –1.309 0.006–0.031 3.15 0.008
SOL 0.029 0.008 1.496 0.012–0.046 3.80 0.003
S1 0.042 0.011 0.965 0.019–0.065 3.99 0.002
Excluded variables: SWS, WASO, gender, RLS duration, S2, S3, S4, SE
S OL = Sleep onset latency; SPT = sleep period time; S1 etc. = stage 1 etc.; WASO = wakening after sleep onset; light sleep (min) = S1 + S2; slow-wave 
sleep (min) SWS = S3 + S4; REM-S = REM sleep; SE = sleep efficiency; CI = confidence interval; R = multiple correlation coefficient; R2 = multiple coef-
ficient of determination.
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REM-sleep. A prolonged SOL was predicted by age, fe-
male gender, reduced SE, increased wakening after sleep 
onset (amount and duration), a markedly prolonged SOL, 
and shortened S3. In sum, poor sleep as extracted from 
the sleep log was predicted by gender, age, RLS duration, 
and by fragmented sleep, increased light sleep and de-
creased deep sleep.
 Prediction of Occurrence of RLS, Depressive 
Symptoms, and Sleep Complaints at Follow-Up 
 Further computations showed that at follow-up, RLS, 
depressive symptoms (BDI sum score) and sleep com-
plaints (sum score, Insomnia Severity Index, ISI) were in-
tercorrelated; RLS, BDI; r = 0.47, p  ! 0.001; RLS, ISI: r = 
0.59, p  ! 0.001; BDI, ISI: r = 0.77, p  ! 0.001. Thus, the 
question arose as to whether polysomnographic sleep 
variables could predict RLS, depressive symptoms, and 
sleep complaints. Multiple regression analyses with the 
polysomnographic variables as predictors and the occur-
rence of RLS, depressive symptoms (sum score BDI) and 
sleep complaints as dependent variables showed that nei-
ther the polysomnographic sleep variables as a whole, nor 
specific polysomnographic sleep variables were of predic-
tive value. R’s and R 2 ’s were between 0.75 and 0.85, though 
ANOVAs revealed that multiple correlation coefficients 
did not significantly differ from 0 (p  1 0.1). Thus, poly-
somnographic values could predict neither RLS, nor de-
pressive symptoms, nor sleep complaints.
Table 3. M ultiple linear regression models to describe the influence of objective sleep, age, and gender on subjective sleep from the 
daily sleep log
Dimension Variables Coeffi-
cient
Standard
error
Coeffi-
cient, 
95% CI t p R R2 Durbin-
Watson-
statistics
Sleep-related mood, Intercept 16.951 7.36 – 3.489–37.391 2.30 0.08 0.99 0.97 1.31
concentration and RLS duration 0.066 0.020 0.715 0.010–0.122 3.26 0.031
sleep quality Gender –1.152 0.362 –0.503 –2.157–0.0147 3.18 0.033
Age 0.047 0.013 0.527 0.01–0.0185 3.53 0.024
WASO 0.0174 0.041 1.74 0.060–0.289 4.22 0.013
WASO, time 0.075 0.009 4.40 0.049–0.101 7.90 0.001
SOL 0.031 0.007 1.77 0.011–0.051 4.31 0.013
SE 0.175 0.064 2.803 0.002–0.353 2.74 0.052
S2 0.064 0.010 4.11 0.036–0.092 6.31 0.003
S4 –0.100 0.028 –1.227 –0.178–0.022 –3.56 0.024
REM-S 0.0139 0.025 4.09 0.079–0.209 5.54 0.005
Excluded variables: SWS, S1, S3, RLS duration
Sleep duration and Intercept 1.449 2.087 – 3.272–6.171 0.694 0.51 0.86 0.74 1.47
sleep fragmentation RLS duration 0.092 0.028 0.895 0.028–0.156 3.26 0.010
Gender –1.538 0.673 –0.601 –3.061 to –0.016 2.28 0.048
SPT 0.037 0.012 2.597 0.010–0.064 3.06 0.014
WASO 0.154 0.050 1.374 0.042–0.0266 3.11 0.012
S1 0.055 0.018 1.249 0.015–0.059 3.14 0.012
S4 –0.049 0.034 –1.028 –0.016 to –0.172 2.72 0.024
Excluded variables: SWS, Age, S2, S3, REM-S, SOL
Sleep onset latency Intercept 16.275 4.935 – 5.280–27.270 3.29 0.008 0.90 0.81 1.80
Gender –0.943 0.355 –0.549 –1.734 to –0.153 2.68 0.024
SE –0.15 0.044 –3.219 0.054–0.248 3.46 0.006
WASO 0.053 0.018 0.706 0.013–0.093 2.94 0.015
WASO, time 0.069 0.025 1.465 0.013–0.125 2.75 0.020
SOL 0.026 0.005 1.945 0.014–0.038 4.70 0.001
S3 –0.026 0.010 –0.885 –0.004 to –0.049 2.59 0.027
Excluded variables: SWS, S1, S2, S4, RLS duration
SOL = Sleep onset latency; WASO = wakening after sleep onset; light sleep (min) = S1 + S2; slow wave sleep (min) SWS = S3 + S4; REM-S = REM sleep;
SE = sleep efficiency; S1 etc. = Stage 1; CI = confidence interval; R = multiple correlation coefficient; R2 = multiple coefficient of determination.
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 Discussion 
 The key findings of the present study are that greater 
age, polysomnographically assessed increased light sleep 
and decreased deep sleep, along with sleep fragmenta-
tion, could predict poor sleep and poor psychological 
functioning of patients with diagnosed RLS about three 
years after diagnosis. Moreover, RLS duration and medi-
cation did not alter the pattern of results.
 Given the lack of long-term studies focusing on sleep 
and psychological functioning as a function of previous-
ly assessed objective sleep profiles in patients suffering 
from RLS, no specific hypotheses were formulated. In 
this respect, to our knowledge, only a few studies have 
focused on long-term outcomes of psychiatric disorders 
based on polysomnographic recordings at baseline. 
Hatzinger et al.  [54] followed up 15 patients suffering 
from major depressive disorders. At follow-up, about 
three years later, both sleep-EEG recordings and the ac-
tivity of the hypothalamus-pituitary-adrenocortical 
(HPA) axis were assessed. Results suggested that de-
creased slow wave sleep (SWS) variables especially in the 
first sleep period and increased REM density were pre-
dictive for the occurrence of depressive symptoms at fol-
low-up. Additionally, these unfavorable sleep-EEG vari-
ables were also related to excessive stress hormone re-
sponse in the DEX/CRH-test. In sum, unfavorable sleep 
patterns such as decreased SWS and increased REM den-
sity were predictive of unfavorable outcomes of depres-
sive disorders 3 years later. By contrast, in our study, 
REM sleep was of no predictive value. Rather, an entire 
set of specific sleep patterns relating both to sleep archi-
tecture (increased light sleep; decreased deep sleep) and 
sleep continuation (sleep fragmentation), along with age 
and gender, was associated with unfavorable sleep and 
psychological functioning at follow-up. With respect to 
gender, no clear picture emerged: some unfavorable out-
comes were associated both with being male and with 
being female.
 Long-term studies of RLS treatment outcomes have fo-
cused primarily on effects of medication  [32–38] , but the 
findings have been inconsistent. Whereas some studies 
have reported a marked decrease in RLS  [37] and out-
standing efficacy of RLS-related medication  [32] , others 
have reported an increase in symptoms  [35] , or only 
symptomatic relief rather than any curative effect  [32] . 
The results of our study are in line with those reporting 
more negative findings  [32] . Importantly, as our data sug-
gest, the presence or absence of medications for RLS, de-
pression or sleep difficulties (i.e. benzodiazepines) had no 
impact on outcomes related to sleep or psychological 
functioning about 3 years later.
 The present data do not allow a closer inspection of the 
specific regimen pursued by every single patient. Thus, 
the data do not provide information on who took what 
compound for how much time at what level of compliance 
or at what dosage. However, notwithstanding the lack of 
these details, the overall pattern supports the speculation 
that patients’ compliance was mixed given that medica-
tion-based treatment was recommended after the diag-
nosis of RLS. Moreover, statistical computations indicat-
ed that the current medication did not systematically bias 
either former sleep EEG variables or current sleep pat-
terns and psychological functioning. How should one ex-
plain a presumably mixed or unsatisfactory level of com-
pliance? First, there is increasing evidence that antide-
pressants such as fluoxetine and selective serotonin 
reuptake inhibitors (SSRIs) may increase periodic leg 
movements and, consequently, also RLS [for detailed dis-
cussions, see ref.  22, 26, 41, 55, 56 ]. However, in this re-
spect, recent findings suggest that the occurrence and du-
ration of SSRI-induced RLS and periodic leg movements 
are more complex  [56] . Second, recent findings suggest an 
association between olanzapine and RLS  [57] . Third, 
both medication tolerance and augmentation effects are 
well-known unwanted, though common side effects  [58–
60] . Summing up, one may speculate that patients did 
alter (increase, reduce, interrupt, and/or quit) the regi-
men, either independently or after consultation with 
their physician, though for unknown reasons and with 
unsatisfactory outcomes.
 However, the pattern of results (‘poor sleep predicts 
poor sleep and poor psychological functioning’) is not 
necessarily specific to the development of RLS. Rather, 
our results fit well with a wealth of long-term research 
related to sleep and psychological functioning. Roberts et 
al.  [6] found that chronic insomnia in adolescents severe-
ly impacted upon physical and psychological health over 
a 12-month period. In a population-based survey of 
adults, Morphy et al.  [7] found that the incidence of in-
somnia at 12 months was 15% among those without in-
somnia at baseline and that this was significantly associ-
ated with baseline anxiety, depression, and pain. More 
importantly, of those who did have insomnia at baseline, 
69% had insomnia at the 12-month follow-up, suggesting 
that insomnia is a persisting disorder. Likewise, Leblanc 
et al.  [8] showed that a 1-year insomnia incidence rate was 
high and several psychological and health factors were 
associated with new-onset insomnia. Specifically, com-
pared to good sleepers, insomnia syndrome incident cas-
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es presented with premorbid psychological vulnerability 
to insomnia, characterized by more marked symptoms of 
depression and anxiety, lower extraversion, higher arous-
ability, and poorer self-rated mental health at baseline. 
These patients also presented with a higher level of bodi-
ly pain and poorer general health. Importantly, this pat-
tern of results indicates that sleep and psychological 
functioning are highly interrelated. Taken together, find-
ings from longitudinal studies show that poor sleep and 
poor psychological functioning do persist over time. As 
our data suggest, this also holds for patients with RLS.
 However, the question arises as to why patients suffer-
ing from RLS should show a similar pattern of results 
even 3 years after diagnosis. The present data do not al-
low a conclusive answer to be drawn. However, the fol-
lowing observations should be taken into account. First, 
poor sleep, almost by definition, is strongly associated 
with depressive disorders  [54] , pain  [61–64] , and somato-
form disorders  [65] . Thus, it is highly conceivable that 
disrupted sleep as a consequence of RLS had resulted in 
poor psychological functioning. Second, another longi-
tudinal study suggests that depressive disorders may lead 
to poor sleep, which in turn may lead to depressive disor-
ders, and that poor sleep and depressive disorders may 
co-occur without common etiology  [66] . The observa-
tions made the present study may speculatively be ex-
plained by a similar pattern of interrelated perturba-
tions. Furthermore, although again speculative, rather 
than a static if-then relation between poor sleep and poor 
psychological functioning, a more dynamic process is 
conceivably at work. As an illustration, the model of Pat-
terson et al. [67] for the development and maintenance of 
children’s coercive behavior proposes that adverse par-
enting styles such as high behavioral and responsive in-
consistency, low control and lack of warmth exacerbate 
an unfavorable childhood temperament (e.g. easily irri-
table, irascible, low tolerance of frustration), negative be-
havior (e.g. oppositional-aggressive, hyperactive), and 
poor intellectual skills (e.g. low degree of fast and accu-
rate information processing), and vice versa. Thus, this 
model claims a reciprocal impact and feedback loop be-
tween the parents’ style and the child’s psychosocial, in-
tellectual and behavioral characteristics over time. Simi-
larly, we may speculate that, over time, poor sleep (due to 
RLS) may lead to poor psychological functioning, and 
that poor psychological functioning may aggravate poor 
sleep in a process of reciprocal interaction.
 It is of note that sleep EEG recordings predicted nei-
ther the degree of RLS, nor depressive symptoms (BDI) 
or sleep complaints (ISI). How should this pattern of re-
sults be interpreted? We think there are five possibilities. 
One is that the current state of RLS, depressive symp-
toms, and sleep complaints may be affected by other fac-
tors, such as current medication (treatment effects) and 
use of substances (caffeine, alcohol), and that these fac-
tors therefore act as confounds between sleep EEG data 
at the sleep-EEG assessment and state at follow-up 33 
months later. A second possibility is that objective mea-
sures and subjective sensations and perceptions may not 
necessarily correspond. Third, it may be that the disease 
process of RLS, which is primarily a peripheral move-
ment disorder, is spreading and influencing neural net-
works and thus sleep and psychological functioning. 
Fourth, other dimensions related to sleep and psycholog-
ical functioning, though not assessed in this study, were 
confounding covariates. The fifth possibility is that there 
really is no association.
 Despite the new findings, several considerations war-
rant against generalization, and these data should be in-
terpreted cautiously. First, the medication intake between 
the first sleep EEG assessment and the follow-up, and the 
possible influence of the medication regimen on the cur-
rent data, remain unclear. However, to tackle this issue, we 
examined the possible confounding effect of current med-
ication both on former sleep EEG variables and on current 
psychological functioning and sleep. It appeared that cur-
rent medication did not systematically influence the data. 
It therefore seems likely that current medication was of 
minor importance. Second, the time lapse between the 
first and the second assessment showed a high interindi-
vidual range, which may have led to a biased pattern of 
results. To tackle this issue, the interindividual difference 
between the first and the second assessment (termed ‘RLS 
duration’) was introduced as a possible confounding vari-
able; as the pattern of results suggests ( tables 2 ,  3 ), the time 
lapse between the first and the second assessment was not 
a confounding variable. Moreover, in our opinion, the 
large interindividual differences in the time lapse provide 
a compelling reflection of both the strengths and the dif-
ficulties of naturalistic studies conducted under clinical 
routine conditions. As a result, long-term observations 
are rare, though, in our view, they are of considerable 
practical relevance. Third, data at follow-up relating to 
psychological functioning were based on self-reports, and 
it is possible that an increased state of depression may have 
biased the pattern of response behavior. Thus, any future 
investigations should employ experts’ ratings and a clini-
cal psychiatric interview as well as a thorough physical 
examination. Though somatic complaints were covered in 
the questionnaire related to quality of life  [52] , it is con-
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
ts
bi
bl
io
th
ek
 M
ed
izi
n 
Ba
se
l  
   
   
   
   
   
  
13
1.
15
2.
21
1.
61
 - 
10
/2
4/
20
17
 2
:1
6:
01
 P
M
 Brand  /Beck  /Hatzinger  /Savic  /
Holsboer-Trachsler  
Neuropsychobiology 2011;63:92–102100
ceivable that somatic complaints not assessed thus far may 
have negatively influenced current psychological func-
tioning. Fourth, Pearson et al.  [68] observed that, in pa-
tients suffering from RLS, cognitive performance was de-
creased compared to controls; thus, it is possible that the 
pattern of response behavior may have been biased by cog-
nitive impairments. Fifth, sleep patterns were gathered 
from subjective sleep reports and not from objective sleep 
registrations such as sleep EEGs or actigraphy, and again 
a rating bias cannot be excluded. However, the sleep log 
was completed consecutively rather than retrospectively; 
thus, this procedure does not heavily rely on memory and 
is therefore less susceptible to memory failure. Moreover, 
there is evidence that diary-reported sleep patterns may 
be as valid as actigraphically estimated sleep behaviors 
 [69, 70] . Additionally, we have been able to show that sub-
jective sleep data from sleep logs provide a good match 
with sleep EEG recordings  [71, 72] . Sixth, no objective as-
sessment of RLS was performed; this may be of particular 
concern because recent findings suggest that adding re-
sponse to dopaminergic medication improved the accu-
racy of RLS diagnosis, that is, the risk of mimics was re-
duced  [73] . Seventh, data may potentially be biased be-
cause only patients who were willing and able to complete 
the questionnaires and the daily sleep log for 7 consecu-
tive days volunteered to participate in the study. Last, the 
time lag of about 3 years between diagnosis and follow-up 
is not necessarily comparable to a period of therapy.
 Conclusion 
 In patients with RLS, poor objective sleep almost 3 
years earlier predicted current poor sleep and psycholog-
ical functioning. Moreover, medication regimen seemed 
to have no influence, either favorable or unfavorable. As 
a consequence, we propose that an accurate thorough 
treatment consisting both of psychotherapy and medica-
tion is needed. In this view, one may claim that disorders 
such as RLS are not as easy to treat as it seems, and that 
monitoring should therefore be performed by specialized 
sleep centers throughout rather than by residents.
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